glp-1 drugs and alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline Dementia in Diabetes Mellitus GLP-1 Agonists and Dementia -

doi: 10.1152/AJPHEART.00486.2019 95 WarringtonJPGeorgeEMPaleiACSpradleyFTGrangerJP

When it comes to weight loss, one review and meta-analysis found that taking psyllium before meals for about five months lead to more than a four-pound weight loss in those with overweight and obesity

In the STEP 5 study, participants taking semaglutide lost an average of 15.2% of their body weight over two years, compared with 2.6% in the placebo group

The body weight loss observed in this study opens perspectives for a pharmacological treatment of obesity as an alternative to various procedures of bariatric surgery

Medically reviewed by Mohammed Lakhi Superintendent Pharmacist